Geographically, global immunofluorescence assay market segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2017, North America accounted for largest share of immunofluorescence assay market, followed by Europe and Asia Pacific. Rising incidence of chronic diseases, increasing R&D spending, increasing research activities, favorable government funding opportunities, & presence of key players in this region are major factors driving growth of immunofluorescence assay market in North America.
Download Brochure of Immunofluorescence Assay Market spread across 192 Pages, Profiling 11 Companies and Supported with 165 Tables and 34 Figures is now available at www.rnrmarketresearch.com/contacts…ple?rname=1383946 .
The immunofluorescence assay market is expected to reach USD 2.01 billion by 2023 from an estimated USD 1.51 billion in 2018, at a CAGR of 5.8%. The increasing prevalence of chronic diseases, increasing R&D spending, and increasing healthcare expenditure are the major factors driving the growth of the significant growth drivers of the immunofluorescence assay market.
- Manufacturers of immunofluorescence kits, reagents, and equipment
- Suppliers and distributors of immunofluorescence kits, reagents, and equipment
- Research institutes
- Academic institutions
- Contract research organizations
- Health insurance payers
- Market research and consulting firms
- Venture capitalists and investors
Immunofluorescence assay market is segmented into reagents, instruments, antibodies, kits, and consumables & accessories.
Kits segment is expected to register highest CAGR during forecast period. Growth of this segment primarily attributed to increasing demand for complete solutions from a single-provider, rising prevalence of a number of diseases, increasing R&D spending, & increased government funding for life science research.
More Information on Immunofluorescence Assay Market with Top Trends and Company Profile at www.rnrmarketresearch.com/contacts/1383946 .
The report analyzes the global immunofluorescence assay market by product, type, disease, end user, and region. On the basis of product, the reagents segment accounted for the largest share of the global immunofluorescence assay market in 2017.
The growing applications of biosciences and biotechnology within the pharmaceutical and healthcare fields, the rising prevalence of a number of diseases, growing R&D activities, and government initiatives to strengthen national research capabilities are the factors attributing for the largest share of the reagents segment.
2 Market Ranking of OEM Companies
3 Market Share Analysis
4 Competitive Scenario
5 Product Launches
6 Regulatory Approvals
8 Agreements, Collaborations, and Partnerships
The prominent players in the global immunofluorescence assay market are Thermo Fisher (US), Inova Diagnostics (US), Bio-Rad (US), Abcam (UK), PerkinELmer (US), Merck Millipore (US), Cell Signaling Technology (US), MEDIPAN GMBH (Germany), Sino Biological (China), Danaher (US), and Vector Laboratories (US).
Geographically, the global immunofluorescence assay market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2017, North America accounted for the largest share of the immunofluorescence assay market, followed by Europe and Asia Pacific.
The rising incidence of chronic diseases, increasing R&D spending, increasing research activities, favorable government funding opportunities, and the presence of key players in this region are the major factors driving the growth of the immunofluorescence assay market in North America.
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.